Skip to content

Home
About Us
Oncology
Preclinical Services
Shareholders
News & Resources
Contact Us
English

Menu

Home
About Us
Oncology
Preclinical Services
Shareholders
News & Resources
Contact Us
English

Appointments to the Management Team

September 28, 2017

Invitrocue announces appointments to the management team
43mqfthdp4t17r

Categories ASX Announcements

Post navigation

Preliminary Final Report

Annual Report to Shareholders

Search for:

Recent Posts

Invitrocue announces acquisition of Welala to create life science leadership in Thailand and Asean
Invitrocue’s Onco-PDO test is Singapore’s and world’s first validated and approved Clinical Cancer Drug Screening service for Personalised Oncology
Operational Updates – February 2024
Operational Updates – October 2023
Thailand FDA grants approval for commercial use of MyTruHealth and MyTruAge DNA Methylation Test Kit

GET IN TOUCH

51 Science Park Road, #01-11/13 The Aries, Singapore Science Park II Singapore 117586

GENERAL / PHARMACOLOGY ENQUIRIES:

+65 6460 0497
contact@invitrocue.com

ONCO-PDO ENQUIRIES:

+65 6819 0181
onco-pdo@invitrocue.com

SAC - SINGLAS Accredited Laboratory

SERVICES

Home
About Us
Oncology
Preclinical Services
Investors
News & Resources
Contact Us

Icon-twitter-x Facebook-f Linkedin-in Youtube

© Copyright 2024 Invitrocue. All rights reserved
Impressum | Privacy Policy | Cookies Policy | Cookie Settings